短期課程

短期課程以教學和互動的形式提供關於特定主題的深入資訊。參加者和講師之間的一對一互動可以更輕鬆地涵蓋主要演示文稿中可能未涵蓋的技術方面。

短期課程僅限線下參加

Sunday, May 10, 2026

SC1: In silico and Machine Learning Tools for Antibody Design and Developability Predictions

Vinodh B. Kurella, PhD, Research Scientific Associate Director, Global Biologics, Takeda Pharmaceuticals, Inc.
Tanmoy Sanyal, PhD, Principal Data Scientist, Large Molecule Discovery Group, Amgen
Valentin Stanev, PhD, Associate Principal Data Scientist, AstraZeneca
Ben Williams, PhD, Research Software Engineer, Department of Statistics, University of Oxford

SC2: AI-Driven Predictive Preclinical Models: Rethinking the Role of Animal Testing

Sathy Balu-Iyer, PhD, Professor, Pharmaceutical Sciences, SUNY Buffalo
Panagiota (Pegy) Foteinou, PhD, Senior Director, Preclinical and Early Development, Bristol Myers Squibb
Jochem Gokemeijer, PhD, Distinguished Scientist Biologics, Biologics Discovery, Johnson & Johnson
Timothy Hickling, PhD, Consultant, Quasor Ltd.
Vibha Jawa, PhD, Chief Scientific Officer, Epivax Inc.
Pooja Khanna, PhD, Senior Scientist, Merck
Guilhem Richard, PhD, CTO, EpiVax Inc.

SC3: Challenges and Opportunities in Solid Tumor and Autoimmune Disease Therapeutics

Tony R. Arulanandam, DVM, PhD, CEO and Founder, Synaptimmune Therapeutics

SC4: Unlocking Immunity: Mastering Epitope Analysis and Prediction with IEDB and CEDAR Tools & Insights

Nina Blazeska, Senior Project Manager, IEDB and CEDAR Resources, La Jolla Institute for Immunology
Zeynep Kosaloglu-Yalcin, PhD, Instructor, La Jolla Institute for Immunology

SC5: Safety & Efficacy of Bispecifics and ADCs

Rakesh Dixit, PhD, DABT, CEO & President, Bionavigen Oncology, LLC; CSO, TMAB Therapeutics, Regio Biosciences

Tuesday, May 12, 2026

SC6: Developability of Bispecific Antibodies

Nimish Gera, PhD, Independent Consultant

SC7: Targeting the Target: Aligning Target and Biologic Format Biology to Achieve Desired Outcomes

Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC; Entrepreneur in Residence, FairJourney Biologics

SC8: The Dark Proteome: Unlocking Novel Targets for Next-Generation Biologics

Sudhakaran Prabakaran, Co-Founder & CEO, NonExomics

SC9: Automation in Action: Hands-on, Liquid Handling for Protein & Antibody Engineering

Curtis Walton, PhD, Director of Automation and Process Optimization, Institute for Protein Innovation

SC10: Best Practices and Advanced Applications for Label-Free Interaction Analysis in Therapeutic Antibody Discovery

Yasmina Abdiche, PhD, Senior Vice President, Exploratory Research, OmniAb Inc.

* 活動內容有可能不事先告知作更動及調整。

Choose your language
Chinese
Japanese
Korean
English

早期優惠
12月12日前報名參加
最高可優惠 $650OFF
Download Event at a Glance
Present a Poster
2026年 方案

顯示:

      論題      
      日期      
Engineering
工程學分會
Oncology
腫瘍分會
Bispecific Antibodies
多特異性分會
Immunotherpary
免疫療法分會
Expression
蛋白質表達分會
Analytical
分析法分會
Immunogenicity
免疫原性分會
Emerging Modalities
新興治療分會
Machine Learning Stream
機器學習分會
Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEW   Nona_Biosciences_NEW